Neutron brachytherapy in the modern era: Indications and evidence
Cancer/Radiothérapie · 2023-04 · 27 (2) · 170-177
DOI: 10.1016/j.canrad.2022.08.010 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer/Radiothérapie, 2023-04. Verfasst von P Loap und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Institut Curie, Paris, France. Electronic address: pierre.loap@gmail.com. Hauptthemen laut MEDLINE: Brachytherapy, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Hadrontherapy is a form of radiation therapy (RT) that relies on heavy particles, such as proton, heavy ions, or neutrons, to enhance anti-tumoral efficacy based on their specific dosimetric and radio-biological properties. Neutrons are characterized by specific radiobiological properties that might deserve greater consideration, including the high linear energy transfer and the low oxygen enhancement ratio. Neutron brachytherapy, relying on interstitial or intracavitary neutron sources, has been developed since the 1950s using Californium-252 (252Cf) as a mixed emitter of fission fast neutrons and γ-photos. However, the place of NBT in the era of modern radiation therapy is yet to be precisely defined. In this systematic review, we aim to provide an up-to-date analysis of current experience and clinical evidence of NBT in the XXI th century, by answering the following clinical questions: How is NBT currently delivered? What are the current efficacy data and tolerance profiles of NBT?
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Institut Curie, Paris, France. Electronic address: pierre.loap@gmail.com.
- Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy; Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
- Department of Radiation Oncology, Institut Curie, Paris, France.
- Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Zitieren
APA
Loap, P., Barcellini, A., de Marzi, L., Orlandi, E., & Kirova, Y. (2023). Neutron brachytherapy in the modern era: Indications and evidence. Cancer/Radiothérapie, 27(2), 170-177. https://doi.org/10.1016/j.canrad.2022.08.010
Vancouver
Loap P, Barcellini A, de Marzi L, Orlandi E, Kirova Y. Neutron brachytherapy in the modern era: Indications and evidence. Cancer/Radiothérapie. 2023;27(2):170-177. doi:10.1016/j.canrad.2022.08.010
BibTeX
@article{Loap2023,
author = {Loap, P and Barcellini, A and de Marzi, L and Orlandi, E and Kirova, Y},
title = {Neutron brachytherapy in the modern era: Indications and evidence},
journal = {Cancer/Radiothérapie},
year = {2023},
volume = {27},
number = {2},
pages = {170--177},
doi = {10.1016/j.canrad.2022.08.010}
}
EUVIMED